Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
StepStone Group
STEP
$4.28B
| $12M | ﹤0.01% |
280,448
+72,173
| +35% | +$3.19M |
|
1902
Fossil Group
FOSL
$330M
| $12M | ﹤0.01% |
1,009,041
-205,631
| -17% | -$2.66M |
|
|
SWTX
1903
DELISTED
SpringWorks Therapeutics
SWTX
| $11.9M | ﹤0.01% |
188,230
-4,914
| -3% | -$379K |
|
1904
Regenxbio
RGNX
$704M
| $11.9M | ﹤0.01% |
284,700
+19,471
| +7% | +$701K |
|
|
CHCT
1905
Community Healthcare Trust
CHCT
$433M
| $11.9M | ﹤0.01% |
264,077
+7,344
| +3% | +$356K |
|
|
DHC
1906
Diversified Healthcare Trust
DHC
$2.03B
| $11.9M | ﹤0.01% |
3,517,261
+37,079
| +1% | +$140K |
|
1907
MarineMax
HZO
$1.15B
| $11.9M | ﹤0.01% |
245,530
-5,423
| -2% | -$271K |
|
|
TPC
1908
Tutor Perini Cor
TPC
$4.98B
| $11.9M | ﹤0.01% |
915,718
+29,580
| +3% | +$404K |
|
1909
Acco Brands
ACCO
$399M
| $11.9M | ﹤0.01% |
1,381,250
+54,263
| +4% | +$478K |
|
1910
Enterprise Financial Services Corp
EFSC
$2.4B
| $11.8M | ﹤0.01% |
261,036
+50,502
| +24% | +$2.26M |
|
1911
BJ's Restaurants
BJRI
$1.42B
| $11.7M | ﹤0.01% |
280,893
-1,091
| -0.4% | -$45.8K |
|
1912
Revolution Medicines
RVMD
$43.3B
| $11.7M | ﹤0.01% |
425,840
+70,898
| +20% | +$2.06M |
|
|
SAFE
1913
DELISTED
Safehold Inc.
SAFE
| $11.7M | ﹤0.01% |
162,750
-5,101
| -3% | -$433K |
|
|
AMWD
1914
DELISTED
American Woodmark
AMWD
| $11.7M | ﹤0.01% |
178,590
+12,684
| +8% | +$931K |
|
1915
Varex Imaging
VREX
$780M
| $11.7M | ﹤0.01% |
413,743
-14,865
| -3% | -$412K |
|
1916
C4 Therapeutics
CCCC
$502M
| $11.6M | ﹤0.01% |
260,452
+119,858
| +85% | +$5.13M |
|
1917
Pathward Financial
CASH
$1.79B
| $11.6M | ﹤0.01% |
220,897
+1,648
| +0.8% | +$82K |
|
|
INFN
1918
DELISTED
Infinera Corporation Common Stock
INFN
| $11.6M | ﹤0.01% |
1,392,548
+33,534
| +2% | +$304K |
|
|
BWIN
1919
Baldwin Insurance Group
BWIN
$2.99B
| $11.6M | ﹤0.01% |
347,598
+26,512
| +8% | +$830K |
|
|
APTS
1920
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $11.6M | ﹤0.01% |
944,524
+49,328
| +6% | +$558K |
|
1921
Driven Brands
DRVN
$2.12B
| $11.5M | ﹤0.01% |
398,601
+174,336
| +78% | +$5.17M |
|
1922
Huron Consulting
HURN
$2.47B
| $11.5M | ﹤0.01% |
221,417
+6,699
| +3% | +$326K |
|
1923
Schneider National
SNDR
$6.37B
| $11.5M | ﹤0.01% |
504,210
-343
| -0.1% | -$7.58K |
|
1924
American Well
AMWL
$220M
| $11.5M | ﹤0.01% |
62,891
+21,935
| +54% | +$4.76M |
|
1925
Weis Markets
WMK
$1.77B
| $11.5M | ﹤0.01% |
217,999
+10,273
| +5% | +$557K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.